The baxα:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukemia

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 959-965

  Salomons, Gajja S ^a   Brady, Hugh J M ^a   Verwijs Janssen, Manon ^a   Van Den Berg, Joop D ^a   Hart, Augustinus A M ^a   Van Den Berg, Henk ^b   Behrendt, Henk ^b   Hählen, Karel ^c   Smets, Lou A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PROTEIN BAX; PROTEIN BCL 2; THAPSIGARGIN;

ACUTE LEUKEMIA; APOPTOSIS; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHILD; DEXAMETHASONE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; THIOGUANINE; TUMOR CELLS, CULTURED;

EID: 0030982224     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<959::AID-IJC9>3.0.CO;2-X     Document Type: Article

References (23)

1. BRADY, H.J.M., SALOMONS, O.S., BOBELDIJK, R.C. and BERNS, A.J.M., T cells from baxα transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA-damage-induced cell death in the absence of p53. EMBO J., 15, 1221-1230 (1996).
2. CAMPANA, D., COUSTAN-SMITH, E., MANABE, A., BUSCHLE, M., RAIMONDI, S.C., BEHM, F.G., ASHMUN, R., ARICO, M., BIONDI, A. and PUI, C.H., Prolonged survival of B-lineage acute-lymphoblastic-leukemia cells is accompanied by over-expression of bcl-2 protein. Blood, 81, 1025-1031 (1993).
3. CAMPOS, L., ROUAULT, J.P., SABIDO, O., ORIOL, P., ROUBI, N., VASSELON, C., ARCHIMBAUD, E., MAGAUD, J.P. and GUYOTAT, D., High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood, 81, 3091-3096 (1993).
4. COUSTAN-SMITH, E., KITANAKA, A., PUI, C.H., MCNINCH, L., EVANS, W.E., RAIMONDI, S.C., BEHM, F.G., ARICO, M. and CAMPANA, D., Clinical relevance of BCL-2 over-expression in childhood acute lymphoblastic leukemia. Blood, 87, 1140-1146 (1996).
5. GAJEWSKI, T.F. and THOMPSON, C.B., Apoptosis meets signal transduction: elimination of BAD influence. Cell, 87, 589-592 (1996).
6. GALA, J.L., VERMYLEN, C., CORNU, G., FERRANT, A., MICHAUX, J.L., PHILIPPE, M. and MARTIAT, P., High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt sub-type at presentation, and is not correlated with the prognosis. Ann. Hematol., 69, 17-24 (1994).
7. + fluxes. Proc. nat. Acad. Sci. (Wash.), 91, 6569-6573 (1994).
8. MARKS, D.I., KURZ, B.W., LINK, M.P., NG, E., SHUSTER, J.J., LAUER, S.J., BRODSKY, I. and HAINES, D.S., High incidence of potential p53 inactivation in poor-outcome childhood acute lymphoblastic leukemia at diagnosis. Blood, 87, 1155-1161 (1996).
9. MAUNG, Z.T., MACLEAN, F.R., REID, M.M., PEARSON, A.D., PROCTOR, S.J., HAMILTON, P.J. and HALL, A.C., The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. Brit. J. Haematol., 88, 105-109 (1994).
10. MIYASHITA, T. and RUED, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80, 293-299 (1995).
11. MIYASHITA, T. and REED, J.C., bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52, 5407-5411 (1992).
12. OLTVAI, Z., MILLIMAN, C. and KORSMEYER, S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax. that accelerates programmed cell death. Cell. 74, 609-619 (1993).
13. PARK, J.R., BERNSTEIN, I.D. and HOCKENBERY, D.M., Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood. 86, 868-876 (1995).
14. PEZZELLA, F., TURLEY, H., KUZU, I., TUNGEKAR, M.F., DUNNILL, M.S., PIERCE, C.B., HARRIS, A., GATTER, K.C. and MASON, D.Y., bcl-2 protein in non-small-cell lung carcinoma. New Engl. J. Med. 329, 690-694 (1993).
15. PEZZELLA, F., TSE, A.G., CORDELL, J.L., PULFORD, K.A., GATTER, K.C. and MASON, D.Y., Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Amer. J. Pathol., 137, 225-232 (1990).
16. PIETENPOL, J.A., PAPADOPOULOS, N., MARKOWITZ, S., WILLSON, J.K., KINZLER, K.W. and VOGELSTEIN, B., Paradoxical inhibition of solid-tumor cell growth by bcl2. Cancer Res., 54, 3714-3717 (1994).
17. REED, J.C., Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. Clin. North Amer., 9, 451-473 (1995).
18. SENTMAN, C.L., SHUTTER, J.R., HOCKENBERY, D., KANAGAWA, O. and KORSMEYER, S.J., bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-888 (1991).
19. SINICROPE, F.A., HART, J., MICHELASSI, F. and LEE, J.J., Prognostic value of bcl-2 oncoprotein in stage-II colon carcinoma. Clin. Cancer Res., 1, 1103-1110 (1995).
20. SMETS, L.A., SLATER, R., VAN WERING, E.R., VAN DER DOES-VAN DEN BERG, A., HART, A.A., VEERMAN, A.J. and KAMPS, W.A., DMA index and %S-phase cells determined in acute lymphoblastic leukemia of children: a report from studies ALL V, ALL VI, and ALL VII (1979-1991) of the Dutch Childhood Leukemia Study Group and The Netherlands Workgroup on Cancer Genetics and Cytogenetics. Med Pediatr. Oncol., 25, 437-444 (1995).
21. SMETS, L.A., VAN DEN BERG, J., ACTON, D., TOP, B., VAN ROOIJ, H. and VERWIJS-JANSSEN, M., BCL-2 expression and mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid-induced apoptosis. Blood, 84, 1613-1619 (1994).
22. STOETZER, O.J., NUSSLER, V., DARSOW, M., GULLIS, E., PELKA-FLEISCHER, R., SCHEEL, U. and WILMANNS, W., Association of bcl-2. bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. Leukemia, 10(Suppl. 3), S18-S22 (1996).
23. THOMAS, A., EL ROUBY, S., REED, J.C., KRAJEWSKI, S., SILBER, R., POTMESIL, M. and NEWCOMB, E.W., Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53-gene mutation and bcl-2/bax proteins in drug resistance. Oncogene, 12, 1055-1062 (1996).